Removing race information from cardiovascular risk calculators – which predict the probability of developing heart disease – doesn’t affect patients’ risk scores, according to a study by Weill Cornell Medicine and NewYork-Presbyterian investigators.
Researchers at Weill Cornell Medicine have found that controlling high blood pressure may not be enough to prevent associated cognitive declines. The findings suggest new approaches to prevent damage to brain cells.
An interdisciplinary collaboration used a cutting-edge form of RNA tagging to map the gene expression that occurs during follicle maturation and ovulation in mice, an approach that could lead to therapeutic treatments for infertility.
Researchers have identified blood biomarkers that could help pediatricians quickly diagnose severe cases of COVID-19 as well as multisystem inflammatory syndrome, also known as MIS-C, which emerged during the pandemic.
Deer hunters were more likely to be swayed by social media messages about the potential risks of chronic wasting disease if they came from a source they believed aligned with their own views and values.
New research has shown that ultrasmall Cornell Prime Dots, or C’Dots, which are among the nanocarriers for therapeutics once thought to be viable only by injection, have the potential to be administered orally.
A Cornell-led collaboration built a 3D in-vitro model of a functional human lymphatic vessel that revealed a surprising mechanism that can jam up the necessary drainage
The Cornell Jeb E. Brooks School of Public Policy Executive Master of Health Administration (EMHA) was ranked as a top 10 national program based on ratings from the program's alumni.
Openly gay men were more likely than those who conceal their sexual orientation to seek care for mpox last year during a global outbreak that disproportionately affected their community, researchers from Cornell and the University of Toronto found.